Novo Nordisk A/S (NVO)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
171,371,250,000
EV to revenue ratio (TTM)
3.671
EV to ebitda
8.18
Financial Performance
Revenue (TTM)
329,430,991,000
Gross profit (TTM)
270,091,993,000
EBITDA
173,677,003,000
Profitability
Operating margin (TTM)
42.50%
Profit margin
35.30%
Return on assets (TTM)
18.70%
Return on equity (TTM)
59.80%
Per Share Metrics
Revenue per share (TTM)
74.19
EPS
3.99
Diluted EPS (TTM)
3.99
Book value
7.72
Dividend per share
11.7
Dividend yield
4.63%
Valuation Multiples
P/E ratio
9.72
Trailing P/E
9.72
Forward P/E
11.83
PEG ratio
4.321
Price to sales ratio (TTM)
0.52
Price to book ratio (TTM)
4.969
Growth
Quarterly earnings growth (YoY)
2.10%
Quarterly revenue growth (YoY)
-20.60%
Analyst Sentiment
Strong buy
0
Buy
3
Hold
11
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.344